Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19 #MMPMID33933339
Angeli F; Marazzato J; Verdecchia P; Balestrino A; Bruschi C; Ceriana P; Chiovato L; Dalla Vecchia LA; De Ponti R; Fanfulla F; La Rovere MT; Perego F; Scalvini S; Spanevello A; Traversi E; Visca D; Vitacca M; Bachetti T
Eur J Intern Med 2021[Jul]; 89 (?): 81-86 PMID33933339show ga
AIMS: heart failure (HF) and coronary artery disease (CAD) are independent predictors of death in patients with COVID-19. The adverse prognostic impact of the combination of HF and CAD in these patients is unclear. METHODS AND RESULTS: we analysed data from 954 consecutive patients hospitalized for SARS-CoV-2 in five Italian Hospitals from February 23 to May 22, 2020. The study was a systematic prospective data collection according to a pre-specified protocol. All-cause mortality during hospitalization was the outcome measure. Mean duration of hospitalization was 33 days. Mortality was 11% in the total population and 7.4% in the group without evidence of HF or CAD (reference group). Mortality was 11.6% in the group with CAD and without HF (odds ratio [OR]: 1.6, p = 0.120), 15.5% in the group with HF and without CAD (OR: 2.3, p = 0.032), and 35.6% in the group with CAD and HF (OR: 6.9, p<0.0001). The risk of mortality in patients with CAD and HF combined was consistently higher than the sum of risks related to either disorder, resulting in a significant synergistic effect (p<0.0001) of the two conditions. Age-adjusted attributable proportion due to interaction was 64%. Adjusting for the simultaneous effects of age, hypotension, and lymphocyte count did not significantly lower attributable proportion which persisted statistically significant (p = 0.0360). CONCLUSION: The combination of HF and CAD exerts a marked detrimental impact on the risk of mortality in hospitalized patients with COVID-19, which is independent on other adverse prognostic markers.
free
free
free
Eur+J+Intern+Med 2021 ; 89 (?): 81-86
